IONS Q4 2017 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$172M+7.5% YoY

Gross Profit

$44M25.5% margin

Operating Income

-$2M-1.0% margin

Net Income

$3M1.6% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+45.6%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$11M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$957M

Stockholders' Equity

$281M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$172M	$160M	+7.5%
Gross Profit	$44M	$59M	-25.6%
Operating Income	-$2M	$41M	-104.1%
Net Income	$3M	$26M	-89.4%